HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Histopathological classification of pseudomyxoma peritonei and the prognostic importance of PINCH protein.

AbstractAIM:
The aims of this study were i) to assess a new and more detailed histopathological classification and to analyze concordance between pathologists in the histopathological classification of pseudomyxoma peritonei (PMP); ii) to analyze the expression in the stroma of the particularly interesting new cysteine-histidine (PINCH) protein and its prognostic importance in PMP.
MATERIALS AND METHODS:
Surgical specimens from 81 patients, classified according to the Ronnett et al histopathological classification were compared to a new system with four groups ranging from indolent to aggressive growth patterns. PINCH protein expression was analyzed and was related to clinical variables.
RESULTS:
The new four-group classification provided better prognostic information than the classification according to Ronnett et al. (p=0.04). Expression of the PINCH protein in the stroma was found in 83% of the cases and was associated with high tumor burden (p=0.002) and a poor prognosis (p=0.04).
CONCLUSION:
The proposed new PMP classification system may provide additional prognostic information. PINCH protein is expressed in PMP and has prognostic information.
AuthorsHåkan Andréasson, Alkwin Wanders, Xiao-Feng Sun, Roger Willén, Wilhelm Graf, Peter Nygren, Bengt Glimelius, Zhi-Yong Zhang, Haile Mahteme
JournalAnticancer research (Anticancer Res) Vol. 32 Issue 4 Pg. 1443-8 (Apr 2012) ISSN: 1791-7530 [Electronic] Greece
PMID22493383 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Adaptor Proteins, Signal Transducing
  • LIM Domain Proteins
  • LIMS1 protein, human
  • Membrane Proteins
Topics
  • Adaptor Proteins, Signal Transducing (physiology)
  • Adult
  • Aged
  • Female
  • Humans
  • LIM Domain Proteins (physiology)
  • Male
  • Membrane Proteins (physiology)
  • Middle Aged
  • Prognosis
  • Pseudomyxoma Peritonei (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: